Posts by: Joana Carvalho, PhD

Joana Carvalho, PhD

Joana holds a BSc in Biology, a MSc in Evolutionary and Developmental Biology and a PhD in Biomedical Sciences from Universidade de Lisboa, Portugal. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells — cells that made up the lining of blood vessels — found in the umbilical cord of newborns.

May 4, 2020May 4, 2020

Vitamin D Deficiency Linked to Poor Lung Function in Adults With Bronchiectasis

News

Vitamin D deficiency is common in adults with bronchiectasis and may be linked to radiological findings indicative of poor lung function, a study reports. The study, “Vitamin D Deficiency ... Read more

December 5, 2019December 5, 2019

People With Blood Cancers More Prone to Develop Bronchiectasis, Study Finds

News

People with blood cancers are more prone to develop bronchiectasis, which in turn contributes to an increased mortality risk, a study found. The study, “De novo bronchiectasis in haematological ... Read more

October 31, 2019October 31, 2019

Alaxia Joins iABC Consortium to Accelerate Development of ALX-009, Its Lead Antimicrobial Agent

News

Alaxia has joined the inhaled Antibiotics in Bronchiectasis and Cystic Fibrosis (iABC) consortium as a partner in a collaborative project that seeks to accelerate the development of two inhaled ... Read more

October 3, 2019October 3, 2019

Amoxicillin-Clavulanate Recommended to Treat Non-severe Flare-ups of Bronchiectasis in Children, Trial Shows

News

The combination of amoxicillin with clavulanate should remain the oral antibiotic of choice to treat non-severe flare-ups of bronchiectasis in children, results of a Phase 4 trial indicate. The ... Read more

August 1, 2019August 1, 2019

Bronchiectasis Patients Have Worse Quality of Life if Disease is COPD-related and More Severe, Study Says

News

The quality of life of patients with bronchiectasis is heavily affected by the root cause and severity of their disease, with worse quality of life if the cause is ... Read more

May 23, 2019May 23, 2019

Lung Bacteria Composition Tends to Remains Stable, May Correlate with Lung Function in nCFB, Study Says

News

The composition of bacteria living inside the lungs of people with non-cystic fibrosis bronchiectasis tends to remain stable over time, and may correlate with patients’ lung function, a study ... Read more

May 17, 2019May 17, 2019

Treatment Algorithm Centered on Chest Physiotherapy May Minimize Lung Function Decline, Study Says

News

A treatment algorithm centered on the use of high-frequency chest wall oscillation (HFCWO) therapy may help minimize lung function decline, hospitalization rate, and the need for oral antibiotics among ... Read more

April 25, 2019

Bronchiectasis and COPD Patients in US Face High Financial Burden, Study Says

News

The financial burden associated with healthcare costs is relatively high for U.S. patients with chronic obstructive pulmonary disease (COPD) or bronchiectasis, especially for those who are affected by both ... Read more

January 10, 2019January 10, 2019

Statins, Mucolytics May Lower Risk of Exacerbations, Death Among BCO Patients, Study Finds

News

Statins and mucolytics may lower the risk of acute exacerbations and death among patients with bronchiectasis and chronic obstructive pulmonary disease (COPD), a Taiwanese study found. The study, “Mucolytic ... Read more

November 15, 2018November 15, 2018

Certain Autoantibodies Linked to P. aeruginosa Infection in Bronchiectasis Patients, Study Suggests

News

Production of autoantibodies against a particular protein called bactericidal/permeability-increased protein (BPI) is strongly associated with chronic Pseudomonas aeruginosa infection in patients with bronchiectasis, a study has found. BPI is an anti-microbial ... Read more

Pin It on Pinterest